Dr. Kaveeta Vasisht is the Associate Commissioner for Women’s Health at the US Food and Drug Administration (FDA). She also directs the FDA Office of Women’s Health (OWH), which serves to protect and advance the health of women through policy development, scientific programs, research, education, collaboration, and outreach. OWH leads efforts to advance regulatory science through understanding sex differences, promoting the inclusion of women and diversity in clinical trials, establishing women’s health research priorities at FDA, and developing educational resources. In addition, OWH works to bridge important knowledge gaps on conditions that uniquely or disproportionately impact women, including pregnancy and lactation.

Dr. Vasisht has served as the medical expert on multidisciplinary teams in the review and evaluation of scientific data to make regulatory decisions on the safety and effectiveness of therapeutics during her tenure in FDA’s Office of New Drugs. She also has extensive expertise in leading regulatory policy development as a Deputy Director in the Office of Medical Policy at FDA.

Dr. Vasisht is board-certified in both internal medicine and adult endocrinology. She completed her internal medicine residency and endocrinology fellowship at the University of Chicago Hospitals, where she also served on faculty. She received her medical degree from UMDNJ Robert Wood Johnson Medical School and also holds a Doctor of Pharmacy degree. Dr. Vasisht is the recipient of the 2023 Health Public Service Visionary Award from the Society for Women’s Health Research (SWHR).